Treating Mild Coronavirus Cases Could Help Save Everyone
The president’s decision is puzzling. And yet it does highlight the urgent need to devote more attention and resources to drugs that can prevent Covid-19 or stop mild cases from getting worse.
To date, about a dozen studies on therapies for Covid-19 have been published; all were conducted on hospitalized patients, typically with severe symptoms.
Some results are sobering: Neither hydroxychloroquine nor a combination of lopinavir and ritonavir, two H.I.V./AIDS medications, seems effective. Other trials show some promise. Remdesivir, a drug developed to treat hepatitis C and Ebola, appears to have accelerated the recovery of some patients with advanced Covid-19, according to an unpublished study sponsored by the National Institute of Allergy and Infectious Diseases.
[Source: New York Times]